MedTrace Logo

MICRO: a Registry Study in Patients With Microvascular Angina

NCT04612322 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2022-03-31

No results posted yet for this study

Summary

The evidence above demonstrates that microvascular dysfunction is an important determinant of patient prognosis, which however remains poorly classified. Given the high burden of disease and the severity of the functional impairment in these patients, the lack of a clear definition for this disease has a potentially large clinical importance. It is important to better describe the phenotype of these patients, identify the predictors of prognosis, and determine the impact of diagnosis.

Conditions

  • Microvascular Disease

Interventions

DEVICE

Assessment of microvascular function with intracoronary hemodilution

The pressure/temperature wire allows assessing coronary flow reserve, intracoronary pressure, and coronary flow to calculate multiple parameters of coronary macro- and microvascular function.

Sponsors & Collaborators

  • Johannes Gutenberg University Mainz

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-10
Primary Completion
2024-10-10
Completion
2029-10-10
FDA Device
Yes

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04612322 on ClinicalTrials.gov